| Literature DB >> 31358791 |
Si-Hyuck Kang1,2, Sun-Hwa Kim1, Jun Hwan Cho1,2, Chang-Hwan Yoon1,2, Seung-Sik Hwang3, Hae-Young Lee2,4, Tae-Jin Youn1,2, In-Ho Chae1,2, Cheol-Ho Kim5,6.
Abstract
The purpose of the present study was to describe the temporal trends in prevalence and management status of hypertension in Korea between 1998 and 2015. Data of adults who were aged 30 years or older were extracted from the Korea National Health and Nutrition Examination Survey, a nationwide representative population-based survey. Hypertension was prevalent in 30.5% of Korean adults. The age and sex standardized prevalence showed little change between 1998 and 2015. The elderly population and men showed higher prevalence. The rates of awareness, treatment, and control showed substantial improvements among hypertensive subjects between 1998 and the time period of 2007‒2009 (awareness, from 23.5 to 66.3%; treatment, from 20.4 to 60.3%; and control, from 4.9 to 42.1%), after which the numbers reached a plateau and no significant changes were observed subsequently (67.3%, 63.6%, and 46.2%, respectively, between 2013 and 2015). The management status remained poor especially among the young population and in men. In conclusion, the hypertension prevalence remained stable at approximately 30% in Korea between 1998 and 2015. While awareness, treatment, and control of hypertension improved remarkably, the young population and particularly men showed a suboptimal management status.Entities:
Mesh:
Year: 2019 PMID: 31358791 PMCID: PMC6662850 DOI: 10.1038/s41598-019-46965-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Characteristics of subjects with hypertension.
| KNHANES I (1998) | KNHANES II (2001) | KNHANES III (2005) | KNHANES IV (2007–2009) | KNHANES V (2010–2012) | KNHANES VI (2013–2015) | |
|---|---|---|---|---|---|---|
| Number of subjects | (n = 6,435) | (n = 5,029) | (n = 4,795) | (n = 14,935) | (n = 15,738) | (n = 13,657) |
| Age | 54.9 ± 0.4 | 57.7 ± 0.5 | 57.1 ± 0.5 | 58.5 ± 0.3 | 59.2 ± 0.3 | 59.8 ± 0.3 |
|
| ||||||
| Male | 51.4% | 47.8% | 53.8% | 52.1% | 51.8% | 53.1% |
| Female | 48.6% | 52.2% | 46.2% | 47.9% | 48.2% | 46.9% |
|
| ||||||
| Body mass index (kg/m2) | 24.4 ± 0.1 | 24.8 ± 1.1 | 25.1 ± 1.1 | 25.0 ± 0.1 | 25.0 ± 0.1 | 25.2 ± 0.1 |
| Waist circumference (cm) | 85.2 ± 0.3 | 86.2 ± 0.3 | 86.7 ± 0.3 | 86.3 ± 0.3 | 85.9 ± 0.2 | 86.4 ± 0.2 |
| Systolic blood pressure (mmHg) | 150.7 ± 0.6 | 146.2 ± 0.6 | 138.8 ± 0.7 | 134.9 ± 0.4 | 135.4 ± 0.3 | 133.4 ± 0.3 |
| Diastolic blood pressure (mmHg) | 91.6 ± 0.3 | 89.0 ± 0.4 | 88.1 ± 0.6 | 84.9 ± 0.3 | 83.1 ± 0.2 | 81.5 ± 0.3 |
| Heart rate (/min) | 73.5 ± 0.3 | 73.4 ± 0.4 | 68.3 ± 0.4 | 65.0 ± 1.7 | 60.5 ± 0.9 | 58.5 ± 0.7 |
|
| ||||||
| Regular physical activity | — | — | — | 47.4% | 35.5% | 36.3% |
| Heavy alcohol drinking | — | — | — | 15.2% | 14.3% | 14.2% |
| Daily calorie intake (kcal) | 1871.7 ± 26.2 | 1846.5 ± 29.0 | 1954.0 ± 32.9 | 1795.2 ± 19.2 | 1923.5 ± 18.6 | 1948.9 ± 18.6 |
| Daily sodium consumption (mg) | 4865.7 ± 111.8 | 5428.4 ± 113.7 | 5551.8 ± 112.7 | 4681.8 ± 68.5 | 4766.6 ± 64.9 | 3742.9 ± 50.7 |
|
| ||||||
| Obesity | 40.9 ± 1.4 | 46.9 ± 1.5 | 50.6 ± 1.5 | 49.1 ± 0.9 | 47.3 ± 0.9 | 50.1 ± 0.9 |
| Diabetes mellitus | — | — | 16.2 ± 1.2 | 20.0 ± 0.7 | 19.5 ± 0.7 | 21.2 ± 0.8 |
| Dyslipidaemia | — | — | 60.6 ± 1.6 | 59.8 ± 1.0 | 57.6 ± 0.9 | 60.4 ± 0.9 |
|
| ||||||
| Total cholesterol (mg/dL) | 200.8 ± 1.0 | 199.8 ± 1.1 | 194.0 ± 1.2 | 195.5 ± 0.8 | 193.7 ± 0.7 | 191.2 ± 0.7 |
| HDL cholesterol (mg/dL) | 48.5 ± 0.3 | 44.5 ± 0.4 | 43.0 ± 0.3 | 45.9 ± 0.2 | 47.4 ± 0.2 | 48.5 ± 0.2 |
| LDL cholesterol (mg/dL) | 124.1 ± 1.1 | 122.7 ± 1.1 | 119.0 ± 1.0 | 115.3 ± 1.9 | 116.7 ± 1.2 | 112.4 ± 0.8 |
| Triglyceride (mg/dL) | 145.4 ± 1.7 | 165.4 ± 2.6 | 185.3 ± 6.1 | 173.2 ± 2.8 | 166.1 ± 2.2 | 169.7 ± 2.6 |
| Fasting glucose (mg/dL) | 109.4 ± 1.1 | 102.4 ± 0.6 | 103.5 ± 1.0 | 106.3 ± 0.5 | 105.1 ± 0.5 | 107.7 ± 0.5 |
| Calculated GFR (mL/min/1.73 m2) | 51.2 ± 0.5 | 57.9 ± 0.6 | 44.7 ± 0.3 | 53.7 ± 0.5 | 51.1 ± 0.3 | 53.1 ± 0.7 |
Data are presented as mean ± SE or % (SE). Log transformed geometric means are presented for triglycerides. HDL denotes high density lipoprotein; LDL, low density lipoprotein; GFR, glomerular filtration rate.
Figure 1Trends in the prevalence of hypertension in Korea: (A) crude prevalence, (B) age-standardized prevalence, (C) prevalence across different age groups, and (D) prevalence according to sex and age in 2013‒2015.
Prevalence, Awareness, Treatment and Control of Hypertension in Korea (2013–2015).
| Prevalence | Awareness | Treatment | Control (1) | Control (2) | |
|---|---|---|---|---|---|
| Total | 30.5 ± 0.6 | 67.3 ± 0.9 | 63.6 ± 0.9 | 46.2 ± 1.0 | 72.0 ± 1.0 |
|
| |||||
| Male | 33.7 ± 0.8 | 60.1 ± 1.4 | 55.4 ± 1.4 | 40.4 ± 1.3 | 72.4 ± 1.4 |
| Female | 27.4 ± 0.6 | 75.4 ± 1.0 | 72.7 ± 1.0 | 52.7 ± 1.2 | 71.7 ± 1.3 |
|
| |||||
| 30–39 | 8.6 ± 0.6 | 20.2 ± 3.2 | 15.2 ± 2.8 | 9.8 ± 2.2 | 64.7 ± 9.3 |
| 40–49 | 19.4 ± 0.9 | 43.9 ± 2.5 | 39.5 ± 2.6 | 29.8 ± 2.4 | 74.9 ± 3.5 |
| 50–59 | 34.0 ± 1.0 | 61.4 ± 1.8 | 56.2 ± 1.8 | 40.1 ± 1.8 | 70.7 ± 2.2 |
| 60–69 | 49.7 ± 1.2 | 82.0 ± 1.2 | 79.3 ± 1.3 | 59.6 ± 1.6 | 74.5 ± 1.6 |
| 70+ | 64.5 ± 1.2 | 86.0 ± 0.9 | 83.4 ± 1.0 | 59.3 ± 1.4 | 70.4 ± 1.5 |
|
| |||||
| Urban area | 29.5 ± 0.6 | 66.9 ± 1.1 | 62.8 ± 1.1 | 45.9 ± 1.1 | 72.4 ± 1.1 |
| Rural area | 34.5 ± 1.4 | 68.8 ± 1.9 | 66.3 ± 2.0 | 47.3 ± 2.2 | 70.9 ± 2.1 |
|
| |||||
| Highest | 28.7 ± 1.0 | 68.0 ± 1.6 | 63.6 ± 1.7 | 46.9 ± 1.7 | 73.1 ± 1.8 |
| Upper middle | 29.5 ± 0.9 | 65.9 ± 1.9 | 62.8 ± 1.8 | 43.9 ± 1.8 | 69.2 ± 2.1 |
| Lower middle | 31.3 ± 1.0 | 63.8 ± 1.7 | 60.4 ± 1.8 | 45.9 ± 1.8 | 75.1 ± 1.8 |
| Lowest | 32.4 ± 1.0 | 71.3 ± 1.7 | 67.6 ± 1.8 | 48.2 ± 1.9 | 71.0 ± 1.9 |
|
| |||||
| Primary | 80.2 ± 1.0 | 80.2 ± 1.0 | 77.3 ± 1.1 | 54.9 ± 1.4 | 70.4 ± 1.4 |
| Middle | 69.2 ± 2.1 | 69.2 ± 2.1 | 63.8 ± 2.2 | 47.7 ± 2.3 | 74.1 ± 2.5 |
| High | 62.0 ± 1.8 | 62.0 ± 1.8 | 47.0 ± 2.8 | 44.6 ± 1.8 | 75.9 ± 1.7 |
| University/college | 48.5 ± 2.3 | 48.5 ± 2.3 | 44.4 ± 2.2 | 31.6 ± 2.0 | 70.9 ± 2.7 |
Data are presented as mean ± SE. Control rate (1), the rate of adequate blood pressure control among individuals with hypertension. Control rate (2), the rate of adequate blood pressure control among those under hypertension treatment.
Figure 2Trends in the awareness of hypertension in Korea: (A) overall awareness and (B) awareness across different age groups.
Figure 3Trends in the treatment of hypertension in Korea: (A) overall treatment and (B) treatment across different age groups.
Figure 4Trends in the control of hypertension in Korea. Control (1) is the rate of control among subjects with hypertension: (A) overall control and (B) control across different age groups. Control (2) is the rate of control among subjects with hypertension who were receiving treatment: (C) overall control and (D) control across different age groups.
Figure 5Temporal trends of mean blood pressure in the general Korean population.